Survivin gene polymorphism association with tongue squamous cell carcinoma

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 1, 2013, Pages 74-77

  Mostaan, Leila Vazifeh ^a   Tabari, Azin ^b   Amiri, Parvin ^c   Ashtiani, Mohammadtaghi Khorsandi ^b   Mahdkhah, Aydin ^b   Yazdani, Nasrin ^b   Khaniki, Mahmood ^d   Tabari, Azadeh ^a   Tavakkoly Bazzaz, Javad ^c   Amoli, Mahsa M ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

SURVIVIN; TUMOR MARKER;

ADULT; ALLELE; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CLINICAL FEATURE; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVIN GENE; TONGUE CARCINOMA;

ADULT; AGED; ALLELES; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; TONGUE; TONGUE NEOPLASMS;

EID: 84871203878     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0210     Document Type: Article

References (38)

1. Ambrosini G, Adida C, Sirugo G, et al. (1998) Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273:11177-11182. (Pubitemid 28204967)
2. Bang CI, Paik SY, Sun DI, et al. (2008) Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line. Ann Otol Rhinol Laryngol 117:781-785.
3. Bayram S, Akkiz H, Bekar A, et al. (2011) The association between the survivin - 31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population. Cancer Epidemiol 35:555-559.
4. Belbin TJ, Schlecht NF, Smith RV, et al. (2008) Site-specific molecular signatures predict aggressive disease in HNSCC. Head Neck Pathol 2:243-256.
5. Borges BD, Burbano RR, Harada ML. (2010) Survivin - 31C/G polymorphism and gastric cancer risk in a Brazilian population. Clin Exp Med 11:189-193.
6. Dai J, Jin G, Dong J, et al. (2010) Prognostic significance of surviving polymorphisms on non-small cell lung cancer survival. J Thorac Oncol 5:1748-1754.
7. De Maria S, Pannone G, Bufo P, et al. (2009) Survivin geneexpression and splicing isoforms in oral squamous cell carcinoma. J Cancer Res Clin Oncol. 135:107-116.
8. Eto M, Kodama S, Uemura N, et al. (2007) Antibody responses to survivin and their clinical significance in patients with head and neck cancer. Head Neck 29:1128-1135.
9. Ferrari D, Carla C, Fiore J, et al. (2009) Biomolecular markers in cancer of the tongue. J Oncol 211:321-330.
10. Freier K, Pungs S, Sticht C, et al. (2007) High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy. Int J Cancer 120:942-946. (Pubitemid 46175418)
11. Forastiere A, Koch W, Trotti A, et al. (2001) Head and neck cancer. N Engl J Med 345:1890-1900. (Pubitemid 33716564)
12. Funk GF, Karnell LH, Robinson RA, et al. (2002) Presentation, treatment, and outcome of oral cavity cancer: a national cancer data base report. Head Neck 24:165-180. (Pubitemid 34111514)
13. Gazouli M, Tzanakis N, Rallis G, et al. (2009) Survivin - 31G/N promoter polymorphism and sporadic colorectal cancer. Int JColorectal Dis 24:145-150.
14. Haghpanah V, Khalooghi K, Adabi K, et al. (2009) Associations between HLA-C alleles and papillary thyroid carcinoma. Cancer Biomark 5:19-22.
15. Jang JS, Kim KM, Kang KH, et al. (2008) Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer 60:31-39. (Pubitemid 351434465)
16. Johnson ME, Howerth EW. (2004) Survivin a binfunctional inhibitor of apoptosis protein. Vet Pathol 41:599-607. (Pubitemid 39573750)
17. Kawata N, Tsuchiya N, Horikawa Y, et al. (2011) Two surviving polymorphisms are cooperatively associated with bladder cancer susceptibility. Int J Cancer 129:1872-1880.
18. Knauer SK, Mann W, Stauber RH. (2007) Survivin's dual role: an export's view. Cell Cycle 6:518-521. (Pubitemid 46440421)
19. Krepela E, Dankova P, Moravcikova E, et al. (2009) Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma. Int J Oncol 35:1449-1462.
20. Lin CY, Hung HC, Kuo RC, et al. (2005) Survivin expression predicts poorer prognosis in patients with areca quid chewing- related oral squamous cell carcinoma in Taiwan. Oral Oncol 41:645-654.
21. Lo Muzio L, Farina A (2005) Survivin as prognostic factor in squamous cell carcinoma of the oral cavity.Cancer Lett 252:27-33. (Pubitemid 40732765)
22. Lo Muzio L, Pannone G, Staibano S, et al. (2003) Survivin expression in oral squamous cell carcinoma. Br J Cancer 89:2244-2248. (Pubitemid 38168006)
23. Lo Muzio L, Staibano S, Pannone G, et al. (2001) Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 70:249-254. (Pubitemid 32607197)
24. Ma F, Zhang H, Zhai Y, et al. (2011) Functional polymorphism - 31C/G in the promoter of BIRC5 gene and risk of asopharyngeal carcinoma among chinese. PLoS One 6:e16748.
25. Marioni G, Ottaviano G, Marchese-Ragona R, et al. (2006) High nuclear expression of the apoptosis inhibitor protein surviving is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma. Acta Otolaryngol 126:197-203. (Pubitemid 43155505)
26. Melet A, Song K, Bucur O, et al. (2008) Apoptotic pathways in tumor progression and therapy. Adv Exp Med Biol 615:47-79.
27. Schantz SP, Yu GP (2002)Head and neck cancer incidence trends in young Americans, 1973-2997, with a special analysis for Tongue ancer. Arch Otolaryngol Head Neck Surg 128:268-274. (Pubitemid 34218579)
28. Srivastava K, Srivastava A, Mittal B (2012) Survivin promoter - 31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis. Mol Biol Rep 39:1509-1516.
29. Theodoropoulos GE, Michalopoulos NV, Panoussopoulos SG, et al. (2010) Effects of caspase-9 and survivin gene polymorphisms in pancreatic cancer risk and tumor characteristics. Pancreas 39:976-980.
30. Thomas GR, Nadiminti H, Regalado J (2005) Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 86:347-363. (Pubitemid 41746374)
31. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
32. Upadhyay R, Khurana R, Kumar S, et al. (2011) Role of surviving gene promoter polymorphism (- 31G > C) in susceptibility and survival of esophageal cancer in northern India. Ann Surg Oncol 18:880-887.
33. Wang YH, Chiou HY, Lin CT, et al. (2009) Association between survivin gene promoter - 31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population. Urology 73:670-674.
34. Woods KV, Shillitoe EJ, Spitz MR, et al. (1993) Analysis of human papillomavirus DNA in oral squamous cell carcinomas. J Oral Pathol Med 22:101-108. (Pubitemid 23155184)
35. Yang L Zhu H Zhou B et al. (2009a) The association between the survivin C-31G polymorphism gastric cancer risk in a Chinese Population. Dig Dis Sci 541021-1028
36. Yang X, Xiong G, Chen X, et al. (2009b) Survivin expression in esophageal cancer: correlation with p53 mutations and promoter polymorphism. Dis Esophagus 22:223-230.
37. Yazdani N, Sayahpour FA, Haghpanah V, et al. (2012) Survivin gene polymorphism association with papillary thyroid carcinoma. Pathol Res Pract 208:100-103.
38. Zahedi P, Aminimoghaddam S, Sayahpour FA, et al. (2012) Association of survivin gene polymorphism with endometrial cancer. Int J Gynecol Cancer 22:35-37.